AbbVie bets $10.9 billion on Apogee in growth push

RTE Monday 22nd June 2026, 2:34PM 1 min read 7 hours ago

AbbVie said today it would buy biotech Apogee Therapeutics for $10.9 billion, in its largest buyout in more than five years to strengthen its next-gen immunology pipeline.

Read original RTE

More from RTE

Byrne backs O'Gara to take over at Leinster

21 minutes ago

Bohemians show their steel to sink Shelbourne

39 minutes ago

Rovers battle back to snatch a point from Derry

49 minutes ago

World Cup 2026: France v Iraq updates

1 hour ago

Related in Business

Canada's inflation rate surges to a 29-month high of 3.2%

8 hours ago

CRH to buy Arcosa in $8.5 billion all-cash deal

8 hours ago

Daa lodges plans for second solar farm at Dublin Airport

10 hours ago

Dept objected to allocating up to 190 extra staff to CRU

11 hours ago